Pharmacokinetics of Etravirine Combined with Atazanavir/Ritonavir and a Nucleoside Reverse Transcriptase Inhibitor in Antiretroviral Treatment-Experienced, HIV-1-Infected Patients by Catherine Orrell, Franco Felizarta, André Nell, Thomas N. Kakuda, Ludo Lavreys, Steven Nijs, Lotke Tambuyzer, Rodica Van Solingen-Ristea, Frank L. Tomaka

Get full text

Efficacy and Safety of Long-acting Injectable Cabotegravir and Rilpivirine in Improving HIV-1 Control in sub-Saharan Africa: Protocol for a Phase 3b Open-Label Randomized Controlle... by Fafa Addo Boateng, Daniel Grint, Eugene Ruzagira, Victoria Babirye Tumusiime, Ingrid Eshun-Wilsonova, Claire Norcross, Fiona Cresswell, Ubaldo Mushabe Bahemuka, Jonathan Kitonsa, Ayoub Kakande, Geofrey Kimbugwe, Fridah Mwendia, David S Lawrence, Veerle Van Eygen, Rodica Van Solingen

Get full text

The 96-week outcomes and pharmacokinetics of long-acting cabotegravir plus rilpivirine in South Africans by Rosie Mngqibisa, Yashna Singh, Catherine Orrell, Johan Lombaard, Sandy Griffith, Conn Harrington, Ronald D’Amico, William Spreen, Marty St Clair, Christine Latham, Louise Garside, Rodica Van Solingen-Ristea, Veerle Van Eygen, Fafa Addo Boateng, Herta Crauwels, Prosperity Eneh, Ingrid Eshun-Wilsonova

Get full text